| Identification | Back Directory | [Name]
Thieno[3,2-b]pyridine-3-carboxylic acid, 7-[5-chloro-2-[2-[5-cyano-2-methyl-6-[(4-methyl-1-piperazinyl)methyl]-4-oxo-7-(trifluoromethyl)-3(4H)-quinazolinyl]ethoxy]phenyl]-5-methyl- | [CAS]
2573979-29-8 | [Synonyms]
eIF4E-IN-3
Thieno[3,2-b]pyridine-3-carboxylic acid, 7-[5-chloro-2-[2-[5-cyano-2-methyl-6-[(4-methyl-1-piperazinyl)methyl]-4-oxo-7-(trifluoromethyl)-3(4H)-quinazolinyl]ethoxy]phenyl]-5-methyl- | [Molecular Formula]
C34H30ClF3N6O4S | [MOL File]
2573979-29-8.mol | [Molecular Weight]
711.15 |
| Hazard Information | Back Directory | [Uses]
eIF4E-IN-3 is a potent inhibitor of eukaryotic initiation factor 4e (eIF4e). eIF4E-IN-3 has the potential for researching eIF4e dependent diseases, including the research of cancer (extracted from patent WO2021003157A1, compound 485)[1]. | [References]
[1] Samuel Sperry, et al. Eif4e-inhibiting 4-oxo-3,4-dihydropyrido[3,4-d]pyrimidine compounds. Patent WO2021003157A1. |
|
|